ロード中...
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
INTRODUCTION: Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1–42 (Aβ1–42) in particular with the potential to influence diagnosis. We aimed to...
保存先:
| 出版年: | Alzheimers Dement (Amst) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4877931/ https://ncbi.nlm.nih.gov/pubmed/27239518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|